The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

A clinical-grade recombinant virus-like particle (VLP) vaccine has been developed to prevent human parvovirus B19 (HPVB19) infection, which can have severe and potentially fatal complications in ...

An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...

In this week's episode of "The Top Line," we’re looking at what goes into manufacturing and supply of flu vaccines. Fierce Pharma’s Zoey Becker chats with Stefan Merlo, vice president of commercial ...

If the government wants to expand U.S. manufacturing, it must invest in the already booming vaccine industry. Vaccines Are Already ‘Made in America’ The push to bring manufacturing back to America ...

Millions of doses were lost due to quality-control issues, the probe found. Between March 2020 and February 2022, vaccine-maker Emergent BioSolutions was forced to discard or destroy up to 400 million ...

MADRID—Moderna and BioNTech have quite a few things in common, one being that both are trying to chart their post-COVID course by reinventing cancer modalities. And both, it seems, have run into the ...

Natal (UKZN) is among key institutions under investigation by the Special Investigating Unit (SIU) over alleged ...

Leaders on the continent have vowed that if there is another pandemic, they won’t be shut out of the vaccine market. By Stephanie Nolen Just 3 percent of all Covid-19 vaccine doses delivered in 2021 ...

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process Expected ...